Insider · CIK 0001415297
Mark J Casey
Files at NVAX (NOVAVAX INC). First filing -, latest -.
In brief
Mark J Casey files SEC Form 4 as officer at NVAX (NOVAVAX INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mark J Casey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Non-Statutory Stock Option NQderivative | +152,000 | $0.00 | $0 | 152,000 | Mar 9, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +37,500 | $0.00 | $0 | 101,445 | Mar 5, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | FTax withholding Common Stock | -11,378 | $9.49 | $108k | 90,067 | Mar 5, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 4,000 | Mar 5, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +4,000 | $0.00 | $0 | 65,159 | Mar 3, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | FTax withholding Common Stock | -1,214 | $10.14 | $12k | 63,945 | Mar 3, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 4,000 | Mar 3, 2026 |
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +101,000 | $0.00 | $0 | 101,000 | Mar 3, 2026 |
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Non-Statutory Stock Opotion NQderivative | +152,000 | $9.09 | $1.4M | 152,000 | Mar 3, 2026 |
| Dec 11, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +41,899 | $0.00 | $0 | 73,972 | Dec 15, 2025 |
| Dec 11, 2025 | NVAX NOVAVAX INC | FTax withholding Common Stock | -12,713 | $6.69 | $85k | 61,159 | Dec 15, 2025 |
| Dec 11, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -41,899 | $0.00 | $0 | 41,899 | Dec 15, 2025 |
| Mar 3, 2025 | NVAX NOVAVAX INC | AGrant or award 2025 Non-statutory Stock Option NQderivative | +169,000 | $7.87 | $1.3M | 169,000 | Mar 5, 2025 |
| Mar 3, 2025 | NVAX NOVAVAX INC | AGrant or award 2025 Restricted Stock Units RSUderivative | +112,500 | $0.00 | $0 | 112,500 | Mar 5, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +4,000 | $0.00 | $0 | 33,187 | Mar 4, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | FTax withholding Common Stock | -1,214 | $8.33 | $10k | 31,973 | Mar 4, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 8,000 | Mar 4, 2025 |
| Dec 11, 2024 | NVAX NOVAVAX INC | MOption exercise Common Stock | +41,900 | $0.00 | $0 | 41,900 | Dec 13, 2024 |
| Dec 11, 2024 | NVAX NOVAVAX INC | FTax withholding Common Stock | -12,713 | $8.82 | $112k | 29,187 | Dec 13, 2024 |
| Dec 11, 2024 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -41,900 | $0.00 | $0 | 83,798 | Dec 13, 2024 |
| Dec 11, 2023 | NVAX NOVAVAX INC | AGrant or award Stock Options (Right to buy)derivative | +144,694 | $0.00 | $0 | 144,694 | Dec 13, 2023 |
| Dec 11, 2023 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +125,698 | $0.00 | $0 | 125,698 | Dec 13, 2023 |
Questions about Mark J Casey
Answered from the filings on this page, as of the latest one.
Is Mark J Casey buying or selling?
Mark J Casey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mark J Casey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark J Casey has 0.
Where does Mark J Casey file Form 4?
Mark J Casey has filed Form 4 at NVAX (NOVAVAX INC) as EVP, Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.